PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Metallocenes”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 163 records · Page 9Linked to original sources

Hexafluoroantimony(V) salts of the cationic Ti(IV) fluoride non metallocene complexes [TiF3(MeCN)3]+ and [TiF2L]2+ (L = 15-Crown-5 and 18-Crown-6). Preparation, characterization and thermodynamic stability.

The cationic titanium fluoride containing complexes [fac-TiF3(MeCN)3][SbF6].MeCN (1), [trans-TiF2(15-Crown-5)][SbF6]2(2) and [trans-TiF2(18-Crown-6)][SbF6]2(2), were prepared by the reaction of TiF4, the molecular ligand and SbF5 in MeCN. Complexes 1-3 were characterized by X-ray single crystal analysis, elemental analysis, IR, NMR and mass spectroscopy. Titanium tetrafluoride reacts with the SbF5 in SO2 with the formation of fac-[TiF3(SO2)3]+, detected by 19F NMR. Application of the volume-based approach to thermodynamics (VBT) offers a means, for the first time, of exploring the energetics surrounding these materials and in the thermodynamic section a discussion of this new approach is provided. It emerges that the basis of the thermodynamic driving force of formation of [TiF3L3][SbF6](s) salts, that enforces the unfavourable [DeltaH degrees =+ 237 (+/-20) kJ mol(-1)] fluoride ion transfer from the Lewis acid TiF4(s) to SbF5(l) to give the hypothetical [TiF3]+[SbF6]-(s), is the higher Ti-L (L = ligand) bond energy in the cationic complexes [TiF3L3]+ as compared to that in the molecular adducts TiF4L2(s) and SbF5L(s) so giving rise to larger enthalpies of complexation of [TiF3]+(g) by 3L(g) compared to those for complexation of TiF4(g) by 2L(g) and SbF5(g) by 1L(g). Formation of the trans-[TiF2(15-Crown-5)]2+ and trans-[TiF2(18-Crown-6)]2+ is accounted for the stabilization of [TiF2]2+ cation by the five donor acceptor Ti-O contacts and the accompanying positive charge delocalization. Cationic titanium(IV) complexes fac-[TiF3MeCN)3-nLn]+(n= 0-3) and cis-[TiF318-Crown-6)]+, trans-[TiF2(Crown)]2+(Crown = 15-Crown-5 and 18-Crown-6) were obtained in MeCN solution by the reaction of fac-[TiF3(MeCN)3]+ and L = Et2, THF, H2 or crown ethers. Complexes fac-[TiF3(MeCN)3-nLn][SbF6] L = Et2, THF, H2O, crown ethers are unstable in MeCN solution and slowly decompose giving molecular complexes cis-TiF4L2, cis-TiF4(Crown), SbF5L, titanium oxofluoride and alkoxide complexes. The structure of the fac-[TiF3(MeCN)3]+ is similar to the fac-[TiCl3(MeCN)3]+ and the complexes trans-[TiF2L]2+ L = 15-Crown-5, 18-Crown-6 have very similar geometries to that of trans-[TiCl2(15-Crown-5)]+ showing that the essential features of coordination are the same for the cationic titanium chloride and fluoride complexes with MeCN and 15-Crown-5, 18-Crown-6.

Journal Article↗

Carbohydrate-metallocene conjugates: selective formation of a zirconadioxacyclopentane-type dimer from the reaction of a bis(enolate)ZrCp2 reagent with a glucofuranoside derivative.

The zirconocene enolate complex bis(2-propenolato)ZrCp2 (1) reacts with two molar equivalents of the 1,2,3,4-O-tetramethyl-alpha-D-glucopyranoside (2) with liberation of two equivalents of acetone to yield cleanly the bis(carbohydrate)zirconcene complex (3). Alternatively 1 and the "bifunctional" glucose derivative 3-O-benzyl-1,2-O-isopropylidene-glucofuranoside (4) react to the corresponding zirconadioxacyclopentane-type metallacyclic product that was isolated as the respective dimer (5) featuring a sequence of linearly anellated five-, four-, five-membered metallacycles. Both carbohydrate zirconocene complexes 3 and 5 were characterized by NMR experiments as well as by X-ray diffraction.

Carbohydrate Conformation↗

Biochemistry of metallocenes. Identification of the major metabolite of acetylruthenocene.

1. After oral administration of acetylruthenocene to rats, metabolites were detected in bile and urine. 2. The major metabolite, which is present in both bile and urine, is a glucuronide with the structure: C5H5-Ru-C5H4-CO-CH2-O-C6H9O6 3. The metabolite was identified by mass spectrometry of the permethylated glucuronide and mass spectrometry and n.m.r. of the aglycone. 4. The nature of the metabolite is discussed, and a comparison is made with the metabolism of the benzene analogue, acetophenone.

Animals↗

Metallocene-catalyzed alkene polymerization and the observation of Zr-allyls.

Single-site polymerization catalysts enable exquisite control over alkene polymerization reactions to produce new materials with unique properties. Knowledge of catalyst speciation and fundamental kinetics are essential for full mechanistic understanding of zirconocene-catalyzed alkene polymerization. Currently the effect of activators on fundamental polymerization steps is not understood. Progress in understanding activator effects requires determination of fundamental kinetics for zirconocene catalysts with noncoordinating anions such as [B(C6F5)4]-. Kinetic NMR studies at low temperature demonstrate a very fast propagation rate for 1-hexene polymerization catalyzed by [(SBI)Zr(CH2SiMe3)][B(C6F5)4] [where SBI is rac-Me2Si(indenyl)2] with complete consumption of 1-hexene before the first NMR spectrum. Surprisingly, the first NMR spectrum reveals, aside from uninitiated catalyst, Zr-allyls as the sole catalyst-containing species. These Zr-allyls, which exist in two diastereomeric forms, have been characterized by physical and chemical methods. The mechanism of Zr-allyl formation was probed with a trapping experiment, leading us to favor a mechanism in which Zr-polymeryl undergoes beta-H transfer to metal without dissociation of coordinated alkene followed by sigma-bond metathesis to form H2 and Zr-allyl. Zr-allyl species undergo slow reactions with alkene but react rapidly with H2 to form hydrogenation products.

Journal Article↗

Design of metallocenic drugs.

Studies on structure-activity relationships of organometallic anticancer drugs are reviewed. Three methods for the development of new structures are described. Drug targeting: platinum complexes with oestrophilic ligands were synthesized, and the endocrine and cytostatic effects are discussed. Quantitative structure-activity relationship determination is presented as a rational method for the design of active compounds. The molecular modelling technique is used for the analysis of molecular properties.

Animals↗

[On the biological action of transition metal complexes. 4. The antiviral activity of metallocene dichlorides of titanium and molybdenum (author's transl)].

In view of the fact that bis cyclopentadienyl metal dihalides are known to be anti-tumour drugs, we have investigated the antiviral activity of this type of coordination compounds. Bis cyclopentadienyl titanium dichloride (a) has shown significant antiviral efficiency in vitro against representatives of a nuber of enveloped DNA and RNA viruses. Inhibition of orthopoxvirus (vaccinia), herpes virus (pseudorabies), orthomyxoviruses (influenza A/fowl plague [FPV], influenza A/Victoria 3/75, influenza A/jena 48/78 and influenza B/Johannesburg), paramyxovirus (Newcastle disease [NDV]) and rhabdovirus (vesicular stomatitis [VSV]) was observed after direct contact with the compound under loss of infectivity up to 100%. Regarding the group of unenveloped viruses only adenovirus type 4 became influenced but not type 5. No antiviral activity could be found against the cardiovirus Mengo. The compound bis cyclopentadienyl molybdenum dichloride failed to show an antiviral action versus vaccinia, influenza A/FPV and influenza viruses B/Johannesburg. Application of the inhibitor (a) during the replication of vaccinia and influenza viruses A/FPV in cell cultures produced an additional effect of inhibition of virus multiplication. On the other hand, adenovirus type 4 and VSV replication was not affected by titanocene dichloride.

Adenoviridae↗